Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4590-4594, September 1, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coffey, R. J.
Right arrow Articles by Moses, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coffey, R. J., Jr.
Right arrow Articles by Moses, H. L.

Transforming Growth Factor {alpha} and ß Expression in Human Colon Cancer Lines: Implications for an Autocrine Model1

Robert J. Coffey, Jr., Anton S. Goustin2, Ann Mangelsdorf Soderquist, Gary D. Shipley3, Jana Wolfshohl, Graham Carpenter and Harold L. Moses4

Departments of Cell Biology [R. J. C., J. W., H. L. M.], Biochemistry [A. M. S., G. C.], and Medicine [R. J. C.], Vanderbilt University, Nashville, Tennessee 37232, and Department of Cell Biology [A. S. G., G. D. S.], Mayo Clinic, Rochester, Minnesota 55905

Three human colon cancer lines (SW480, SW620, WIDR) secrete different levels of transforming growth factor ß (TGFß)-like and transforming growth factor {alpha} (TGF{alpha})/epidermal growth factor (EGF)-like molecules into serum-free conditioned media as measured by competing activity in TGFß and EGF radioreceptor assays. SW480 cells, the highest producers of TGFß-like activity, lack detectable TGFß receptors while SW620 cells, the highest producers of TGF{alpha}/EGF-like activity, lack EGF receptors. This study investigated the production of these growth factors at the mRNA level and examined the mechanism of loss of detectable receptors. Using complementary DNA probes for TGFß and TGF{alpha}, it was demonstrated that mRNA levels correlated with the amounts of TGFß and TGF{alpha} produced; TGFß gene expression was highest in SW480 cells and TGF{alpha} gene expression was highest in SW620 cells. Acid washing of the SW480 cells prior to performing the TGFß binding assay resulted in the unmasking of substantial levels of TGFß receptors. Neither acid washing nor preincubation with suramin uncovered EGF receptors in SW620 cells. Also, and in contrast to the other two lines, EGF receptor expression could not be detected in SW620 cells by Northern gel analysis of receptor messenger RNA or by immunological analysis of receptor protein. Thus two distinct mechanisms (occupation of TGFß receptor in SW480 cells, or absence of EGF receptor in SW620 cells) explain the lack of detectable TGFß and EGF receptors in the binding assays. The autocrine hypothesis remains viable for TGFß in SW480 cells but not for TGF{alpha} in SW620 cells; this would not discount a paracrine role in this latter case.

1 This investigation was supported by USPHS grants CA42572, CA42749, CA42750 (H. L. M.); CA24071 (A. M. S., G. C.); and CA42409 (G. D. S.).

2 Present address: Center for Blood Research, Boston, MA 02115.

3 Present address: Department of Cell Biology and Anatomy, Oregon Health Sciences, Portland, OR 97201.

4 To whom requests for reprints should be addressed.

Received 3/ 6/87. Revised 5/26/87. Accepted 6/ 2/87.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S.-R. Shiou, A. B. Singh, K. Moorthy, P. K. Datta, M. K. Washington, R. D. Beauchamp, and P. Dhawan
Smad4 Regulates Claudin-1 Expression in a Transforming Growth Factor-{beta}-Independent Manner in Colon Cancer Cells
Cancer Res., February 15, 2007; 67(4): 1571 - 1579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rajput, A. P. Koterba, J. I. Kreisberg, J. M. Foster, J. K.V. Willson, and M. G. Brattain
A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo
Cancer Res., January 15, 2007; 67(2): 665 - 673.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. P. Spano, R. Fagard, J.-C. Soria, O. Rixe, D. Khayat, and G. Milano
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
Ann. Onc., February 1, 2005; 16(2): 189 - 194.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J.-P. Spano, C. Lagorce, D. Atlan, G. Milano, J. Domont, R. Benamouzig, A. Attar, J. Benichou, A. Martin, J.-F. Morere, et al.
Impact of EGFR expression on colorectal cancer patient prognosis and survival
Ann. Onc., January 1, 2005; 16(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Song, B. Yu, Y. Wei, M. G. Wientjes, and J. L.-S. Au
Low-Dose Suramin Enhanced Paclitaxel Activity in Chemotherapy-Naive and Paclitaxel-Pretreated Human Breast Xenograft Tumors
Clin. Cancer Res., September 15, 2004; 10(18): 6058 - 6065.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Vodovotz, L. Chesler, H. Chong, S.-J. Kim, J. T. Simpson, W. DeGraff, G. W. Cox, A. B. Roberts, D. A. Wink, and M. H. Barcellos-Hoff
Regulation of Transforming Growth Factor {beta}1 by Nitric Oxide
Cancer Res., May 1, 1999; 59(9): 2142 - 2149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Jiang, H. Yang, J. K. V. Willson, J. Liang, L. E. Humphrey, E. Zborowska, D. Wang, J. Foster, R. Fan, and M. G. Brattain
Autocrine Transforming Growth Factor alpha  Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth States
J. Biol. Chem., November 20, 1998; 273(47): 31471 - 31479.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Zhou, P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J. Le Dai, S. E. Kern, K. W. Kinzler, and B. Vogelstein
Targeted deletion of Smad4 shows it is required for transforming growth factor beta  and activin signaling in colorectal cancer cells
PNAS, March 3, 1998; 95(5): 2412 - 2416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Yamamoto, K. Fujihashi, K. Kawabata, J. R. McGhee, and H. Kiyono
A Mucosal Intranet: Intestinal Epithelial Cells Down-Regulate Intraepithelial, But Not Peripheral, T Lymphocytes
J. Immunol., March 1, 1998; 160(5): 2188 - 2196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Chinery, J. A. Brockman, D. T. Dransfield, and R. J. Coffey
Antioxidant-induced Nuclear Translocation of CCAAT/Enhancer-binding Protein beta . A CRITICAL ROLE FOR PROTEIN KINASE A-MEDIATED PHOSPHORYLATION OF Ser299
J. Biol. Chem., November 28, 1997; 272(48): 30356 - 30361.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kirkland and K Henderson
Endocrine and mucous differentiation by a cloned human rectal adenocarcinoma cell line (HRA-19) in vitro: inhibition by TGF-beta 1
J. Cell Sci., January 4, 1994; 107(4): 1041 - 1046.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.